Investigational Site Number : 804002

Zaporizhzhya 69600

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Hematological Malignancy

Studies at this site

• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed
• Evaluation of Dupilumab in Children With Uncontrolled Asthma — Completed